Clinical and pharmacological group: & nbsp

Enzymes and antiferments

Included in the formulation
  • Abomin®
    pills inwards 
  • АТХ:

    A.09.A.A   Enzyme preparations

    Pharmacodynamics:

    Proteolytic enzyme, acts on food (mainly milk) proteins.

    Pharmacokinetics:

    Not absorbed.

    Indications:

    Diseases of the gastrointestinal tract, accompanied by a violation of the digestive capacity of gastric juice, including:

    - Achilles;

    - hypo- and anacid gastritis;

    - indigestion;

    - conditions after resection of the stomach;

    - gastritis;

    - gastroenteritis;

    - Enterocolitis.

    XI.K20-K31.K29   Gastritis and duodenitis

    XI.K20-K31.K30   Dyspepsia

    XI.K50-K52.K52   Other non-infectious gastroenteritis and colitis

    XI.K90-K93.K91.1   Syndromes of operated stomach

    Contraindications:

    Children under 14 years (for this dosage form).

    Hypersensitivity to the drug.

    Pregnancy and lactation:

    Adequate and well-controlled studies in humans and animals have not been conducted. There is no information on the penetration into breast milk.

    The category of the FDA recommendation is not defined.

    Dosing and Administration:

    Children over 14 years of age and adults are prescribed 1 tablet per os. 3 times / day during meals for 1-2 months. With insufficient effectiveness, a single dose can be increased to 2-3 tablets. at the reception, and the course of treatment was extended to 3 months.

    Side effects:

    From the digestive system: nausea, heartburn.

    Other: allergic reactions.

    Overdose:

    Not described.

    Interaction:

    Not described.

    Special instructions:

    Distinctive characteristics.

    The drug obtained from the mucous membrane of the stomach of calves and lambs of milk age.

    Instructions
    Up